Nargenicin attenuates lipopolysaccharide-induced inflammatory responses in BV-2 cells

NeuroReport

Volumn 20, Issue 11, 2009, Pages 1007-1012

  Yoo, Jin Cheol ^a   Cho, Hong Suk ^a   Park, Euteum ^a   Park, Jeong Ae ^a   Kim, Seung ^a   Kim, Do Kyung ^a   Kim, Chun Sung ^a   Kim, Sung Jun ^a   Chun, Hong Sung ^a  

^a Chosun University   (South Korea)

Author keywords

BV 2 cells; Cytokines; Lipopolysaccharide; Nargenicin; Nitric oxide

Indexed keywords

ANTIINFLAMMATORY AGENT; I KAPPA B KINASE ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NARGENICIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG EFFECT; INFLAMMATION; MICROGLIA; MOUSE; NOCARDIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; LACTONES; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; NOCARDIA; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 67749124149     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32832d2239     Document Type: Article

References (24)

1. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001; 2:734-744.
2. Nguyen MD, Julien JP, Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 2002; 3:216-227.
3. Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, et al. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 2008; 13:709-717.
4. Liu B,Wang K, Gao HM, Mandavilli B, Wang JY, Hong JS. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem 2001; 77:182-189. (Pubitemid 32245092)
5. Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 2002; 133:27-35. (Pubitemid 34146496)
6. Ruano D, Revilla E, Gavilan MP, Vizuete ML, Pintado C, Vitorica J, et al. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection. Neuroscience 2006; 140:1157-1168. (Pubitemid 43928265)
7. Jung DY, Lee H, Jung BY, Ock J, Lee MS, Lee WH, et al. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J Immunol 2005; 174:6467-6476. (Pubitemid 40663842)
8. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-145.
9. Jantzie LL, Rauw GA, Todd KG. The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia. Neurochem Int 2006; 49:717-728.
10. Wang AL, Yu AC, Lau LT, Lee C, Wu LM, Zhu XA, et al. Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 2005; 47:152-158. (Pubitemid 40848704)
11. Celmer WD, Chmurny GN, Moppett CE, Ware RS, Watts PC, Whipple EB. Structure of natural antibiotic CP-47,444. J Am Chem Soc 1980; 102:4203-4209.
12. Sohng JK, Yamaguchi T, Seong CN, Baik KS, Park SC, Lee HJ, et al. Production, isolation and biological activity of nargenicin from Nocardia sp. CS682. Arch Pharm Res 2008; 31:1339-1345.
13. Cho HS, Kim S, Lee SY, Park JA, Kim SJ, Chun HS. Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology 2008; 29:656-662.
14. Filipovic R, Zecevic N. Neuroprotective role of minocycline in co-cultures of human fetal neurons and microglia. Exp Neurol 2008; 211:41-51.
15. Lee SM, Yune TY, Kim SJ, Kim YC, Oh YJ, Markelonis GJ, et al. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J Neurochem 2004; 91:568-578.
16. Fernandez-Gomez FJ, Gomez-Lazaro M, Pastor D, Calvo S, Aguirre N, Galindo MF, et al. Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death. Neurobiol Dis 2005; 20:384-391. (Pubitemid 41476264)
17. Tsuji M, Wilson MA, Lange MS, Johnston MV. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 2004; 189:58-65. (Pubitemid 39024455)
18. Lee JC, Ahn TH, Kang SS, Moon C, Bae CS, Kim SH, et al. Single oral dose toxicity evaluation of CS682, a fermentation product of Korean soil bacteria, in rats. Lab Anim Res 2007; 23:401-404.
19. Hou RC, Chen HL, Tzen JT, Jeng KC. Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport 2003; 14:1815-1819.
20. Shen S, Yu S, Binek J, Chalimoniuk M, Zhang X, Lo SC, et al. Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int 2005; 47:298-307. (Pubitemid 40943472)
21. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100:2417-2423.
22. Hald A, Lotharius J. Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp Neurol 2005; 193:279-290.
23. Christman JW, Blackwell TS, Juurlink BH. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol 2000; 10:153-162.
24. Abraham E. NF-kappaB activation. Crit Care Med 2000; 28:N100-N104.